1. Hypoxia inducible factor‐1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia‐induced angiogenesis in lung cancer
    Hongjun Zhu et al, 2018, Journal of Cellular Biochemistry CrossRef
  2. Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?
    Hui Wang et al, 2019, Cancers CrossRef
  3. Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance
    Katrien Konings et al, 2020, Frontiers in Oncology CrossRef
  4. The relationship between the preoperative plasma level of HIF-1α and clinic pathological features, prognosis in non-small cell lung cancer
    Jiabei He et al, 2016, Scientific Reports CrossRef
  5. Exploring hypoxic biology to improve radiotherapy outcomes
    Chun Li et al, 2022, Expert Reviews in Molecular Medicine CrossRef
  6. Digoxin Downregulates NDRG1 and VEGF through the Inhibition of HIF-1α under Hypoxic Conditions in Human Lung Adenocarcinoma A549 Cells
    Dong Wei et al, 2013, International Journal of Molecular Sciences CrossRef
  7. To Overcome Radiation Resistance
    Junichi Saitoh, 2017, The KITAKANTO Medical Journal CrossRef
  8. The Use of Radioprotective Agents to Prevent Effects Associated with Aging
    V. N. Bykov et al, 2019, Biology Bulletin CrossRef
  9. Radio-sensitization effect of an mTOR inhibitor, temsirolimus, on lung adenocarcinoma A549 cells under normoxic and hypoxic conditions
    Hiroki Ushijima et al, 2015, Journal of Radiation Research CrossRef
  10. The dosimetric enhancement of GRID profiles using an external collimator in pencil beam scanning proton therapy
    Blake R. Smith et al, 2022, Medical Physics CrossRef
  11. Influence of inhomogeneous radiosensitivity distributions and intrafractional organ movement on the tumour control probability of focused IMRT in prostate cancer
    Benedikt Thomann et al, 2018, Radiotherapy and Oncology CrossRef
  12. Prognostic histological markers in oral tongue squamous cell carcinoma patients treated with (chemo)radiotherapy
    Aini Hyytiäinen et al, 2023, APMIS CrossRef